Pascal-Francis CNRS

Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("AURANOFINE")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 203

  • Page / 9
Export

Selection :

  • and

THE EFFECT OF A NEW ANTIRHEUMATIC DRUG, TRIETHYLPHOSPHINE GOLD (AURANOFIN), ON IN VITRO LYMPHOCYTE AND MONOCYTE CYTOTOXICITYRUSSELL AS; DAVIS P; MILLER C et al.1982; JOURNAL OF RHEUMATOLOGY; ISSN 0315-162X; CAN; DA. 1982; VOL. 9; NO 1; PP. 30-35; BIBL. 14 REF.Article

L'Auranofine améliore le devenir des malades atteints de polyarthrite rhumatoïde débutante: résultats à 2 ans d'une étude contrôlée en double aveugle contre placebo = Auranofin improves out come in early rheumatoid arthritis. Results from a 2 years double blind. Placebo controlled studyBORG, G; ALLANDER, E; LUND, B et al.Rhumatologie (Aix-les-Bains). 1989, Vol 41, Num 8, pp 247-257, issn 0249-7581, 11 p.Article

Jessner's lymphocytic infiltrate responding to oral auranofinHAFEJEE, A; WINHOVEN, S; COULSON, I. H et al.Journal of dermatological treatment. 2004, Vol 15, Num 5, pp 331-332, issn 0954-6634, 2 p.Article

Arsenic trioxide and auranofin inhibit selenoprotein synthesis : implications for chemotherapy for acute promyelocytic leukaemiaTALBOT, S; NELSON, R; SELF, W. T et al.British journal of pharmacology. 2008, Vol 154, Num 5, pp 940-948, issn 0007-1188, 9 p.Article

Auranofin promotes retinoic acid-or dihydroxyvitamin D3-mediated cell differentiation of promyelocytic leukaemia cells by increasing histone acetylationPARK, S. J; KIM, M; KIM, N. H et al.British journal of pharmacology. 2008, Vol 154, Num 6, pp 1196-1205, issn 0007-1188, 10 p.Article

Effect of a gold-chloroquine complex on inflammation-related leukocyte functions and cell viability : Comparison with auranofinNAVARRO, Maribel; FRAILE, German; VELASQUEZ, Mait et al.Arzneimittel-Forschung. 2006, Vol 56, Num 12, pp 826-833, issn 0004-4172, 8 p.Article

MODULATION OF NEUTROPHIL FUNCTIONS BY AURANOFIN. STUDIES ON EFFECTS IN VITRO AND IN RHEUMATOID ARTHRITIS PATIENTSHAFSTROEM I; UDEN AM; PALMBLAD J et al.1983; SCANDINAVIAN JOURNAL OF RHEUMATOLOGY; ISSN 0300-9742; SWE; DA. 1983; VOL. 12; NO 2; PP. 97-105; BIBL. 27 REF.Article

PHARMAKOLOGISCHE FRAGEN DES KLINIKERS AN AURANOFIN = QUESTIONS PHARMACOLOGIQUES DU CLINICIEN SUR L'AURANOFINMENNINGER H; BURKHARDT H.1983; AKTUELLE RHEUMATOLOGIE; ISSN 0341-051X; DEU; DA. 1983; VOL. 8; SUPPL. 1; PP. 9-13; ABS. ENG; BIBL. 30 REF.Article

THERAPEUTIC INNOVATION IN RHEUMATOID ARTHRITIS. WORLDWIDE AURANOFIN SYMPOSIUM, MONTREAL, CANADA, OCTOBER 20-21, 1981DAVIS P ED; HARTH M ED.1982; J. RHEUMATOL.; ISSN 0315-162X; CAN; DA. 1982; VOL. 9; SUPPL. NO 8; 209 P.; BIBL. DISSEM.Conference Paper

A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lambliaTEJMAN-YARDEN, Noa; MIYAMOTO, Yukiko; LEITSCH, David et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 5, pp 2029-2035, issn 0066-4804, 7 p.Article

Proceedings/Ridaura (auranofin): 1986, a Smith Kline and French international symposium, Amsterdam 21 June 1986DAVIS, T. G.Scandinavian journal of rheumatology. Supplement. 1986, issn 0301-3847, 95 p., suppl. 63Conference Proceedings

Oral gold therapy in rheumatoid arthritis: auranofin, symposium, San Francisco CA, August 3 and 4, 1982BLECHMAN, W. J; GOTTLIEB, N. L.The American journal of medicine. 1983, Vol 75, Num 6, issn 0002-9343, 164 p.Conference Proceedings

Titanate particles as agents to deliver gold compounds to fibroblasts and monocytesDAVIS, Ryan R; HOBBS, David T; KHASHABA, Rania et al.Journal of biomedical materials research. Part A. 2010, Vol 93, Num 3, pp 864-869, issn 1549-3296, 6 p.Article

The role of p38 MAPK activation in auranofin-induced apoptosis of human promyelocytic leukaemia HL-60 cellsPARK, Seon-Joo; KIM, In-Sook.British journal of pharmacology. 2005, Vol 146, Num 4, pp 506-513, issn 0007-1188, 8 p.Article

An open study of auranofin in the treatment of steroid-dependent asthmaBERNSTEIN, D. I; BERNSTEIN, I. L; BODENHEIMER, S. S et al.Journal of allergy and clinical immunology. 1988, Vol 81, Num 1, pp 6-16, issn 0091-6749Article

AURANOFIN (RIDAURAUREG.) UND NATRIUMAUROTHIOMALAT (TAUREDONUD BARRE BEI DER BEHANDLUNG DER CHRONISCHEN POLYARTHRITIS = AURANOFIN (RIDAURA) ET AUROTHIOMALATE DE SODIUM (TAUREDON) DANS LE TRAITEMENT DE LA POLYARTHRITE RHUMATOIDEMUELLER FASSBENDER H; KAIK D; RAU R et al.1983; AKTUELLE RHEUMATOLOGIE; ISSN 0341-051X; DEU; DA. 1983; VOL. 8; SUPPL. 1; PP. 40-43; ABS. ENG; BIBL. 4 REF.Article

MEMBRANOUS GLOMERULONEPHRITIS AS A COMPLICATION OF ORAL GOLD THERAPYPLAZA JJ; HERRERO G; BARAT A et al.1982; ANNALS OF INTERNAL MEDICINE; ISSN 0003-4819; USA; DA. 1982; VOL. 97; NO 4; PP. 563-564; BIBL. 7 REF.Article

AURANOFIN IN THE TREATMENT OF JUVENILE RHEUMATOID ARTHRITISGIANNINI EH; BREWER EJ JR; PERSON DA et al.1983; JOURNAL OF PEDIATRICS; ISSN 0022-3476; USA; DA. 1983; VOL. 102; NO 1; PP. 138-141; BIBL. 13 REF.Article

INHIBITORY EFFECTS OF A NEW ORAL GOLD COMPOUND ON HELA CELLSSIMON TM; KUNISHIMA DH; VIBERT GJ et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 6; PP. 1965-1975; BIBL. 20 REF.Article

MANAGEMENT OF RHEUMATOID ARTHRITIS WITH ORAL GOLDWEISMAN MH; HANNIFIN DM.1979; ARTHRIT. AND RHEUMATISM; USA; DA. 1979; VOL. 22; NO 8; PP. 922-925; BIBL. 8 REF.Article

QUANTITATION OF GOLD LYMPHOCYTE BINDING DURING CHRYSOTHERAPYLORBER A; WILCOX S; LEEB J et al.1979; J. RHEUMATOL.; CAN; DA. 1979; VOL. 6; NO 3; PP. 270-276; BIBL. 18 REF.Article

Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic LeukemiaFISKUS, Warren; SABA, Nakhle; AUSTIN, Christopher P et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 9, pp 2520-2532, issn 0008-5472, 13 p.Article

Synergistic inhibition of human B cell activation by gold sodium thiomalate and auranofinHIROHATA, S; NAKANISHI, K; YANAGIDA, T et al.Clinical immunology (Orlando, Fla. Print). 1999, Vol 91, Num 2, pp 226-233, issn 1521-6616Article

EFFECTS OF GOLD COMPOUNDS ON THE FUNCTION OF PHAGOCYTIC CELLS. II: INHIBITION OF SUPEROXIDE RADICAL GENERATION BY TRIPEPTIDE-ACTIVATED POLYMORPHONUCLEAR LEUKOCYTESDAVIS P; JOHNSTON C; MILLER CL et al.1983; ARTHRITIS AND RHEUMATISM; ISSN 0004-3591; USA; DA. 1983; VOL. 26; NO 1; PP. 82-86; BIBL. 15 REF.Article

REVERSIBLE PROTEINURIA AS A COMPLICATION OF ORAL GOLD THERAPYREVACH M; FREED RL; EHRLICH GE et al.1979; ARTHRIT. AND RHEUMATISM; USA; DA. 1979; VOL. 22; NO 12; PP. 1417-1418; BIBL. 7 REF.Article

  • Page / 9